American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 201–300 of 1,001
Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management
Maynard, G., Kulasa, K., Ramos, P., Childers, D., Clay, B., Sebasky, M., Fink, E., Field, A., Renvall, M., Juang, P. S., et al. (2015) · Endocrine Practice · doi:10.4158/ep14367.or · Cited by 52
“Uncontrolled hyperglycemia and iatrogenic hypoglycemia represent common inpatient quality and safety issues associated with a broad range of adverse outcomes [1-4], and insulin is one of the most common sources of inpatient adverse drug events [2,5,6].”
BackgroundDrincic, A., Pfeffer, E., Luo, J., & Goldner, W. S. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.03.003 · Cited by 38
Update on the management of diabetes in long-term care facilities
Idrees, T., Castro-Revoredo, I. A., Migdal, A. L., Moreno, E. M., & Umpierrez, G. E. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002705 · Cited by 44
Self-citationIncretin Therapies in the Management of Elderly Patients with Type 2 Diabetes Mellitus
Bourdel‐Marchasson, I., Schweizer, A., & Dejager, S. (2011) · Hospital Practice · doi:10.3810/hp.2011.02.369 · Cited by 51
Wang, Y. J., Seggelke, S. A., Hawkins, R. M., Gibbs, J., Lindsay, M. C., Hazlett, I., Wang, C. C. L., Rasouli, N., Young, K. A., & Draznin, B. (2016) · Endocrine Practice · doi:10.4158/ep161414.or · Cited by 51
Golden, S. H., Hager, D. N., Gould, L. J., Mathioudakis, N. N., & Pronovost, P. J. (2016) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2016.10.004 · Cited by 51
Wallia, A., Schmidt, K., Johnson Oakes, D., Pollack, T., Welsh, N., Kling-Colson, S., Gupta, S., Fulkerson, C., Aleppo, G., Parikh, N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3279 · Cited by 42
Primary and Secondary Prevention of Ischemic Stroke
Paciaroni, M., & Bogousslavsky, J. (2010) · European Neurology · doi:10.1159/000285183 · Cited by 50
Diabetes Care After Transplant
Wallia, A., Illuri, V., & Molitch, M. E. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.005 · Cited by 50
Finn, E., Schlichting, L., Grau, L., Douglas, I. S., & Pereira, R. I. (2023) · Diabetes Care · doi:10.2337/dc23-0089 · Cited by 45
Benchmarking Glycemic Control In U.S. Hospitals
Bersoux, S., Cook, C. B., Kongable, G. L., Shu, J., & Zito, D. R. (2014) · Endocrine Practice · doi:10.4158/ep13516.or · Cited by 50
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
Mendez, C. E., & Umpierrez, G. E. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.180 · Cited by 46
Self-citationEffect of a Computerized Insulin Dose Calculator on the Process of Glycemic Control
Dumont, C., & Bourguignon, C. (2012) · American Journal of Critical Care · doi:10.4037/ajcc2012956 · Cited by 50
Inpatient hyperglycemia management: A practical review for primary medical and surgical teams
Lansang, M. C., & Umpierrez, G. E. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83.s1.06 · Cited by 50
Self-citationSchaupp, L., Donsa, K., Neubauer, K. M., Mader, J. K., Aberer, F., Höll, B., Spat, S., Augustin, T., Beck, P., Pieber, T. R., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0343 · Cited by 47
Management of Hyperglycemia and Diabetes in the Emergency Department
Echouffo-Tcheugui, J. B., & Garg, R. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0883-2 · Cited by 49
Addition of Insulin to Parenteral Nutrition for Control of Hyperglycemia
McCulloch, A., Bansiya, V., & Woodward, J. M. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607117722750 · Cited by 49
CGM in the Hospital: Is It Ready for Prime Time?
Buschur, E., Faulds, E. R., & Dungan, K. M. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01484-x · Cited by 49
Glycemic control in hospitalized patients not in intensive care: beyond sliding-scale insulin.
Nau, K. C., Lorenzetti, R. C., Cucuzzella, M. T., Devine, T., & Kline, J. M. (2010) · PubMed · Cited by 49
Westphal, G. A., Filho, M. C., Vieira, K. D., Zaclikevis, V. R., Bartz, M. C. M., Wanzuita, R., Réa-Neto, Á., Teixeira, C., Franke, C. A., Machado, F. O., et al. (2011) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2011000300004 · Cited by 48
Reexamining the evidence for inpatient glucose control: New recommendations for glycemic targets
Moghissi, E. S. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100171 · Cited by 48
“For the majority of noncritically ill patients treated with insulin, the premeal BG target should generally be <140 mg/dL in conjunction with random BG values of <180 mg/dL, provided these targets can be safely achieved.(42,43) To avoid hypoglycemia, consideration should be given to reassessing the insulin regimen if…”
BackgroundInfluentialSelf-citationManagement of Parenteral Nutrition in Hospitalized Adult Patients
Mundi, M. S., Nystrom, E. M., Hurley, D. L., & McMahon, M. M. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607116667060 · Cited by 48
Lo, C., Jun, M., Badve, S. V., Pilmore, H., White, S. L., Hawley, C., Cass, A., Perkovic, V., & Zoungas, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966.pub2 · Cited by 41
Perioperative Management of Patients with Diabetes
Leung, V., & Ragbir-Toolsie, K. (2017) · Health Services Insights · doi:10.1177/1178632917735075 · Cited by 48
Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis
Kang, Z.-Q., Huo, J.-L., & Zhai, X. (2018) · Endocrine Connections · doi:10.1530/ec-18-0231 · Cited by 47
Mandel, S. R., Langan, S., Mathioudakis, N. N., Sidhaye, A. R., Bashura, H., Bie, J. Y., Mackay, P., Tucker, C., Demidowich, A. P., Simonds, W. F., et al. (2019) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2019.1593782 · Cited by 45
Glycemic Control in the Medical Intensive Care Unit
Kovalaske, M. A., & Gandhi, G. Y. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300613 · Cited by 47
Glucose control in acute brain injury: does it matter?
Godoy, D. A., Behrouz, R., & Napoli, M. D. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000292 · Cited by 48
Diabeto-anaesthesia: A subspecialty needing endocrine introspection
Bajwa, S. J., & Kalra, S. (2012) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.104564 · Cited by 47
Gómez-Huelgas, R., Guijarro, R., Zapatero, A., Barba, R., Guijarro-Contreras, A., Tinahones, F. J., & Bernal-López, M. R. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.018 · Cited by 46
Abuannadi, M., Kosiborod, M., Riggs, L. A., House, J. A., Hamburg, M. S., Kennedy, K. F., & Marso, S. P. (2012) · Endocrine Practice · doi:10.4158/ep12196.or · Cited by 46
Abegaz, T. M., Mekonnen, G. A., Gebreyohannes, E. A., & Gelaye, K. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264626 · Cited by 46
“• Hypoglycemia is defined as a blood glucose level�70 mg/Dl [26, 27].”
BackgroundThe Diagnosis and Management of Cerebrovascular Disease in Diabetes
Phipps, M., Jastreboff, A. M., Furie, K. L., & Kernan, W. N. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0271-x · Cited by 46
Pasquel, F. J., Lansang, M. C., Khowaja, A., Urrutia, M. A., Cardona, S., Albury, B., Galindo, R. J., Fayfman, M., Davis, G., Migdal, A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1940 · Cited by 45
Self-citationIbrahim, A., Ghaleb, R., Mansour, H. M., Hanafy, A., Mahmoud, N. M., Elsharef, M. A., Salama, M. K., Elsaughier, S. M., Abdel-Wahid, L., Mohamed, M. E., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.602251 · Cited by 45
“Subcutaneous regular insulin every 6 h was used according to blood glucose level (22).”
MethodConcentrated insulins: Clinical update of therapeutic options
Umpierrez, G. E., Holt, E. H., Einhorn, D., & McGill, J. B. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0607 · Cited by 44
Self-citationThe association of postoperative glycemic control and lower extremity procedure outcomes
Vogel, T. R., Smith, J. B., & Kruse, R. L. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.01.053 · Cited by 44
“According to the American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement, serum blood glucose levels for the majority of non-critically ill patients should aim for blood glucose values <180 mg/dl as long as this target can be safely achieved.(13, 14) Using the patient’s…”
BackgroundEvaluation of clinical decision support systems for diabetes care: An overview of current evidence
Jia, P., Zhao, P., Chen, J., & Zhang, M. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12968 · Cited by 36
Diabetes in the Emergency Department and Hospital: Acute Care of Diabetes Patients
Ford, W., Self, W. H., Slovis, C. M., & McNaughton, C. D. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-012-0007-x · Cited by 44
“Tight glycemic control is a standard that should be accepted and strived for in all hospitals settings [41, 45].”
BackgroundInfluentialPerioperative Glucose Control in Neurosurgical Patients
Godoy, D. A., Napoli, M. D., Biestro, A., & Lenhardt, R. (2012) · Anesthesiology Research and Practice · doi:10.1155/2012/690362 · Cited by 44
“Plasma glucose samples are the gold standard (about 11% higher than obtained by whole blood) by conventional laboratory methods [8], but obtaining them requires extreme precautions to avoid contamination with parenteral solutions.”
BackgroundInfluentialKosiborod, M., & McGuire, D. K. (2010) · Circulation · doi:10.1161/circulationaha.109.913368 · Cited by 43
Management of type 2 diabetes mellitus in the elderly
Soe, K. K., Sacerdote, A. S., Karam, J., & Bahtiyar, G. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.07.006 · Cited by 43
Cardona, S., Gomez, P. C., Vellanki, P., Anzola, I., Ramos, C., Urrutia, M. A., Haw, J. S., Fayfman, M., Wang, H., Galindo, R. J., et al. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000607 · Cited by 38
Self-citationJämsen, E., Nevalainen, P. I., Eskelinen, A. P., Kalliovalkama, J., & Moilanen, T. P. S. (2014) · Acta Orthopaedica · doi:10.3109/17453674.2014.987064 · Cited by 43
“Taking into account that clinical guidelines (Moghissi et al. 2009, Umpierrez et al. 2012, American Diabetes Association 2013) suggest treatment of hyperglycemia > 10.0–11.1 mmol/L, patients with such postoperative glucose values—e.g. the patients with severe hyperglycemia in our study—should also…”
BackgroundInfluentialDungan, K. M., Lyons, S., Manu, K. H., Kulkarni, M., Ebrahim, K., Grantier, C., Harris, C., Black, D., & Schuster, D. (2014) · Endocrine Practice · doi:10.4158/ep14061.or · Cited by 44
Optimal Glucose Management in the Perioperative Period
Evans, C. H., Lee, J., & Ruhlman, M. K. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.11.003 · Cited by 43
Tarigan, T. J. E., Yunir, E., Subekti, I., Pramono, L. A., & Martina, D. (2015) · Medical Journal of Indonesia · doi:10.13181/mji.v24i3.1249 · Cited by 42
Chen, S., Wan, Y., Guo, H., Shen, J., Li, M., Xia, Y., Zhang, L., Sun, Z., Chen, X., Li, G., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14033 · Cited by 42
“GCS, median (IQR) 14 (12, 15) 14 (13, 15) 13 (9, 15) <0.”
Dickerson, R. N., Wilson, V. C., Maish, G. O., Croce, M. A., Minard, G., & Brown, R. O. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112458526 · Cited by 42
Arnold, P. C., Scheurer, D. B., Dake, A. W., Hedgpeth, A., Hutto, A. C., Colquitt, C., & Hermayer, K. L. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2015.11.024 · Cited by 42
Baldwin, D., & Apel, J. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0339-7 · Cited by 42
Brady, V., Thosani, S., Zhou, S., Bassett, R., Busaidy, N. L., & Lavis, V. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0115 · Cited by 39
A guideline for the use of variable rate intravenous insulin infusion in medical inpatients
George, S., Dale, J., Stanisstreet, D., & Care, T. J. B. D. S. (. F. I. (2015) · Diabetic Medicine · doi:10.1111/dme.12756 · Cited by 40
Aizenshtadt, A., Wang, C., Abadpour, S., Menezes, P. D., Wilhelmsen, I., Dalmao‐Fernández, A., Stokowiec, J., Golovin, A., Johnsen, M., Combriat, T. M. D., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303785 · Cited by 39
Management of Hyperglycemia During the Perioperative Period
Pichardo-Lowden, A. R., & Gabbay, R. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0239-2 · Cited by 39
Hyperglycemia and Diabetes Mellitus Following Organ Transplantation
Galindo, R. J., & Wallia, A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0707-1 · Cited by 39
Duggan, E. W., Klopman, M. A., Berry, A. J., & Umpierrez, G. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0720-z · Cited by 39
Self-citationAdult Hyperglycemic Crisis: A Review and Perspective
Steenkamp, D., Alexanian, S. M., & McDonnell, M. E. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0342-z · Cited by 39
“The rare patient with critical illness (eg, shock requiring pressors, mechanical ventilation) or complication (eg, neurological compromise, need for surgery) is best managed by continuing insulin infusion therapy using an institutional variable-rate continuous insulin infusion protocol designed to maintain glucose wit…”
BackgroundBridge over troubled waters: Safe and effective transitions of the inpatient with hyperglycemia
O’Malley, C. W., Emanuele, M., Halasyamani, L. K., & Amin, A. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.355 · Cited by 39
Intensive Insulin Therapy in Critically Ill Hospitalized Patients: Making it Safe and Effective
Klonoff, D. C. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500330 · Cited by 39
Donsa, K., Beck, P., Höll, B., Mader, J. K., Schaupp, L. A., Plank, J., Neubauer, K. M., Baumgärtner, C., & Pieber, T. R. (2016) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2016.03.007 · Cited by 40
The 2012 SEMDSA Guideline for the Management of type 2 Diabetes
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872277 · Cited by 40
Sadoskas, D., Suder, N. C., & Wukich, D. K. (2015) · Foot & Ankle Specialist · doi:10.1177/1938640015593077 · Cited by 38
“control, the ACE and the American Diabetes Association created a consensus statement for inpatient glycemic control.(18) The consensus statement recommends maintaining serum glucose levels in critically ill patients between 140 and 180 mg/dL, using intravenous insulin as the preferred method of glycemic control.”
BackgroundMethodInfluentialAckerbroeck, S. V., Schepens, T., Janssens, K., Jorens, P. G., Verbrugghe, W., Collet, S., Hoof, V. O. V., Gaal, L. V., & Block, C. E. M. D. (2015) · Critical Care · doi:10.1186/s13054-015-1064-9 · Cited by 38
“SH was defined as glucose levels exceeding this threshold of 140 mg/dl, in accordance with the consensus statement [15].”
Olveira, G., Abuín, J., López, R., Herránz, S., García‐Almeida, J. M., García-Malpartida, K., Ferrer, M., Cáncer, E., Pérez, L. M. L., Álvarez, J., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.036 · Cited by 38
“Clinical practice guidelines and consensus statements recommend a target glucose range of 140e180 mg/dL for the majority of non-critically ill patients, but more stringent goals may be appropriate for selected patients if this can be achieved without significant low blood glucose events [8,33].”
BackgroundThe Nurse Education and Transition (NEAT) model: educating the hospitalized patient with diabetes
Krall, J. S., Donihi, A. C., Hatam, M., Koshinsky, J., & Siminerio, L. M. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0020-1 · Cited by 38
Inpatient Continuous Glucose Monitoring and Glycemic Outcomes
Levitt, D. L., Silver, K. D., & Spanakis, E. K. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817698499 · Cited by 38
“1 million hospital days,(5) a significant proportion of which without goal glycemic control, with hyperglycemia detected in up to 38% of all patients associated with increased morbidity and mortality.(6-13) Moreover, hypoglycemia is detected in up to 30% of Type 2 Diabetes Mellitus (T2DM) patients treated with subcuta…”
BackgroundHyperglycemia in Acute Coronary Syndromes
Kosiborod, M. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.11.002 · Cited by 37
The role of hyperglycemia in acute illness: Supporting evidence and its limitations
Corathers, S. D., & Falciglia, M. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.013 · Cited by 37
Standards of care for diabetes: What's new?
Funnell, M. M. (2010) · Nursing · doi:10.1097/01.nurse.0000388314.83393.bd · Cited by 37
Perioperative Surgical Care Bundle Reduces Pancreaticoduodenectomy Wound Infections
Lavu, H., Klinge, M. J., Nowcid, L. J., Cohn, H. E., Grenda, D. R., Sauter, P. K., Leiby, B. E., Croker, S. P., Kennedy, E. P., & Yeo, C. J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.09.028 · Cited by 37
The Place for Glycemic Control in the Surgical Patient
May, A. K., Kauffmann, R. M., & Collier, B. R. (2011) · Surgical Infections · doi:10.1089/sur.2011.019 · Cited by 37
“The complexities of this topic, the data produced by various trials, and the conflicting results have produced disparate consensus guidelines and recommendations by national organizations [11,122].”
Preoperative Preparations for Enhanced Recovery After Surgery Programs
Baldini, G., Ferreira, V., & Carli, F. (2018) · Surgical Clinics of North America · doi:10.1016/j.suc.2018.07.004 · Cited by 37
Errors in fluid therapy in medical wards
Mousavi, M., Khalili, H., & Dashti‐Khavidaki, S. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9620-8 · Cited by 37
“7%) of these diabetic patients had uncontrolled blood sugar defined as random blood sugar over 180 mg/dL or pre-meal blood sugar over 140 mg/dL [18].”
BackgroundA clinician's guide to the treatment of foot burns occurring in diabetic patients
Jones, L. M., Coffey, R., Khandelwal, S., Atway, S. A., Gordillo, G. M., Murphy, C. V., Fries, J. A., & Dungan, K. M. (2014) · Burns · doi:10.1016/j.burns.2014.01.026 · Cited by 36
Zelada, H., Perez‐Guzman, M. C., Cherñavvsky, D. R., & Galindo, R. J. (2023) · Endocrine Connections · doi:10.1530/ec-23-0180 · Cited by 36
“As new studies provided efficacy and safety evidence, basal-bolus insulin regimen became the standard of care for glycemic control for non-critically ill, and continuous insulin infusion the standard of care for the critically-ill population, as recommended by several clinical practice guidelines (7-10).”
BackgroundDesimone, M. E., Blank, G. E., Virji, M. A., Donihi, A. C., DiNardo, M. M., Simak, D. M., Buranosky, R. A., & Korytkowski, M. T. (2012) · Endocrine Practice · doi:10.4158/ep11277.or · Cited by 36
Self-citationvan Steen, S. C. J., Rijkenberg, S., Sechterberger, M. K., DeVries, J. H., & van der Voort, P. H. J. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1045 · Cited by 36
Singh, L. G., Levitt, D. L., Satyarengga, M., Pinault, L. F., Zhan, M., Sorkin, J. D., Fink, J. C., Umpierrez, G. E., & Spanakis, E. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819889640 · Cited by 36
Self-citation2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 5. Post-cardiac arrest care
Kim, T. Y., Jeung, K. W., Kim, W. Y., Park, Y. S., Oh, J. S., You, Y., Lee, D. H., Chae, M. K., Jeong, Y. J., Kim, M. C., et al. (2021) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.21.025 · Cited by 36
Galindo, R. J., Dhatariya, K., Peralta, F. G., & Umpierrez, G. E. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01464-1 · Cited by 36
Self-citationSchroeder, J. E., Liebergall, M., Raz, I., Egleston, R., Ben Sussan, G., Peyser, A., & Eldor, R. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1217 · Cited by 33
“This ‘golden pathway’ has recently been advocated in the American Diabetes Association and the American Association of Clinical Endocrinologists consensus statement [14] and may be preferable in high-demand departments such as orthopaedic surgery.”
BackgroundMetabolic Management during Critical Illness: Glycemic Control in the ICU
Inzucchi, S. E., & Honiden, S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1565253 · Cited by 36
Self-citationMularski, K., Yeh, C. P., Bains, J. K., Mosen, D. M., Hill, A. K., & Mularski, R. A. (2012) · The Permanente Journal · doi:10.7812/tpp/11-131 · Cited by 36
“Protocol Development and Training of the Glycemic Conrol Team Pharmacists The GCT protocol(20) was created by the pharmacy clinical coordinator who worked closely with physicians experienced in inpatient diabetes management from the Endocrinology, Hospitalist, and Surgery Departments, using principles defined by guide…”
BackgroundMethodHospital management of hyperglycemia
Lleva, R. R., & Inzucchi, S. E. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283447a6d · Cited by 35
Self-citationDungan, K. M., Osei, K., Nagaraja, H. N., Schuster, D. P., & Binkley, P. F. (2010) · Endocrine Practice · doi:10.4158/ep10093.or · Cited by 35
“This relationship was observed despite otherwise acceptable glycemic control.(18) It is possible that inpatient glycemic control is simply a surrogate for long-term glycemia (as determined by HbA1c), particularly since short-term readmission rates were unrelated to glycemia.”
BackgroundWu, E. Q., Zhou, S., Yu, A., Lu, M., Sharma, H., Gill, J., & Graf, T. (2012) · Hospital Practice · doi:10.3810/hp.2012.10.1002 · Cited by 33
Insulin therapy in critically ill patients
Ellahham, S. H. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s14203 · Cited by 35
Management of type 1 diabetes in the hospital setting
Mendez, C. E., & Umpierrez, G. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0919-7 · Cited by 34
Self-citationHyperglycaemia in acute lacunar stroke: A Chinese hospital-based study
Fang, Y., Zhang, S., Wu, B., & Liu, M. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112459663 · Cited by 34
Olveira, G., García‐Luna, P. P., Pereira, J. L. S., Rebollo, I., García‐Almeida, J. M., Serrano, P., Rocamora, J. A. I., Muñoz-Aguilar, A., Molina, M. A. J., & Tapia, M. J. (2012) · PubMed · doi:10.3305/nh.2012.27.6.6076 · Cited by 34
“Some studies also suggest that stricter control of blood glucose levels in critically ill patients with and without diabetes could improve their prognosis.(5,18,26,42) In the case of patients receiving TPN (both in critically ill and non-critically ill patients), it seems that hyperglycaemia per se, possibly independe…”
BackgroundMethodThe Mealtime Challenge: Nutrition and Glycemic Control in the Hospital
Ryan, D. B., & Swift, C. S. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.163 · Cited by 34
Management of critically ill patients with diabetes
Silva-Perez, L. J., Benitez-Lopez, M. A., Varón, J., & Surani, S. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i3.89 · Cited by 34
Leung, C.-H., & Liu, C.-P. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.06.005 · Cited by 34
Pérez-Belmonte, L., Gómez-Doblas, J., Millán-Gómez, M., López-Carmona, M., Guijarro-Merino, R., Carrasco-Chinchilla, F., De Teresa-Galván, E., Jiménez-Navarro, M., Bernal-López, M., & Gómez-Huelgas, R. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090271 · Cited by 34
“In addition, apart from the role of incretin-based therapies on stimulation of insulin secretion and reduction of glucagon secretion, the increase of postprandial incretins as glucagon-like peptide-1 could potentially affect glucose regulation through multiple effects, such as a delay in gastric emptying and a decreas…”
BackgroundDon’t Sugar Coat It: Glycemic Control in the Intensive Care Unit
Stoudt, K., & Chawla, S. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618801748 · Cited by 34
“Additional suggestions by the same groups include the consideration for different target ranges for different subpatient groups and the implementation of a hypoglycemia management protocol.(41,42) Similarly, the Surviving Sepsis Campaign has also recently revised their guidelines, recommending treating stress hypergly…”
Maynard, G., Schnipper, J. L., Messler, J., Ramos, P., Kulasa, K. M., Nolan, A., & Rogers, K. M. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814532237 · Cited by 33
“Uncontrolled hyperglycemia and iatrogenic hypoglycemia represent common quality and safety issues associated with a broad range of adverse outcomes,(2-4) and insulin is one of the most common sources of inpatient adverse drug events.(2,5,6) Professional societies and standards organizations have highlighted the import…”
BackgroundKlingbeil, K. D., Koch, S., & Dave, K. R. (2017) · International Journal of Stroke · doi:10.1177/1747493017743797 · Cited by 33
“As of 2009, the American Association of Clinical Endocrinologists and American Diabetes Association came together to define hypoglycemia as plasma glucose less than 70mg/dL.(50) In the trials that defined hypoglycemia at a lower value, episodes of milder hypoglycemia were most likely overlooked.”
BackgroundGlucose Management Technologies for the Critically Ill
Salinas, P. D., & Mendez, C. E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822838 · Cited by 33
Rodríguez, A., Magee, M. F., Ramos, P., Seley, J. J., Nolan, A., Kulasa, K. M., Caudell, K. A., Lamb, A., MacIndoe, J. H., & Maynard, G. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.197 · Cited by 32
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.